0
Abstract: Poster Presentations |

Evaluation of Near-Infrared Spectroscopy for Diagnosis and Treatment of Methemoglobinemia in a New Zealand Rabbit Model FREE TO VIEW

Naglaa H. El-Abbadi, BS; Reza Mina-Araghi, MD; Jangwoen Lee, PhD; Nevine Mikhail-Hanna, BS; Albert Cerussi, PhD; Bruce Tromberg, PhD; Andrew Duke, MD; William Waite, BS; Tanya Burney, BS; Matthew Brenner, MD
Author and Funding Information

Beckman Laser Institute, Irvine, CA


Chest


Chest. 2003;124(4_MeetingAbstracts):179S-a-180S. doi:10.1378/chest.124.4_MeetingAbstracts.179S-a
Text Size: A A A
Published online

Abstract

BACKGROUND:  Frequency Domain Photon Migration (FDPM) is a non-invasive infrared monitoring technology that functions by directing an intensity modulated monochromatic light source at the tissue of interest. Simultaneous determination of absorption and scattering provides the capability for non-invasive direct measurement of tissue metabolite composition. FDPM could potentially be used to monitor changes in various metabolic parameters such as methemoglobin (MetHgb) and methylene blue concentrations during treatment in vivo.

PURPOSE:  The purpose of this study is to evaluate the feasibility of FDPM to non-invasively monitor metabolic events, such as the extent of methemoglobinemia and reversal using methylene blue in vivo.

METHODS:  In vivo detection of methemoglobinemia was evaluated in a New Zealand Rabbit model via intravascular injection of amyl nitrite, and the effects were assessed using FDPM monitoring with a prototype device constructed in our laboratory. The FDPM data were then compared to standard arterial blood gas measurements of MetHgb using a co-oximeter.

RESULTS:  In vivo, MetHgb concentration quantitatively measured by FDPM was compared to %MetHgb obtained through arterial blood gas measurements. Rapid development of methemoglobinemia following amyl nitrite injection was non-invasively tracked, as shown in the figureincluded.

CONCLUSIONS & CLINICAL IMPLICATIONS:  Our results demonstrate the feasibility of monitoring MetHgb levels in tissue non-invasively via FDPM. The ability to non-invasively measure metabolic parameters may someday be useful for assessing and treating conditions such as methemoglobinemia and cyanide toxicity.

DISCLOSURE:  N.H. El-Abbadi, TRDRP# 9RT-0094, grant monies; Air Force D/F49620-00-10371, grant monies.

Wednesday, October 29, 2003

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543